Epidemiology of hepatitis E in South-East Europe in the "One Health" concept.


Journal

World journal of gastroenterology
ISSN: 2219-2840
Titre abrégé: World J Gastroenterol
Pays: United States
ID NLM: 100883448

Informations de publication

Date de publication:
07 Jul 2019
Historique:
received: 11 03 2019
revised: 16 05 2019
accepted: 31 05 2019
entrez: 24 7 2019
pubmed: 25 7 2019
medline: 7 1 2020
Statut: ppublish

Résumé

The significance of hepatitis E virus (HEV) as an important public health problem is rising. Until a decade ago, cases of HEV infection in Eur-ope were mainly confined to returning travelers, but nowadays, hepatitis E represents an emerging zoonotic infection in many European countries. The aim of this manuscript is to perform a systematic review of the published literature on hepatitis E distribution in humans, animals and environmental samples ("One Health" concept) in the South-Eastern European countries. Comparison of the available data showed that the anti-HEV seroprevalence in the South-Eastern Europe varies greatly, depending on the population studied, geographical area and methods used. The IgG seroprevalence rates in different population groups were found to be 1.1%-24.5% in Croatia, up to 20.9% in Bulgaria, 5.9-%17.1% in Romania, 15% in Serbia, up to 9.7% in Greece and 2%-9.7% in Albania. Among possible risk factors, older age was the most significant predictor for HEV seropositivity in most studies. Higher seroprevalence rates were found in animals. HEV IgG antibodies in domestic pigs were detected in 20%-54.5%, 29.2%-50%, 38.94%-50% and 31.1%-91.7% in Serbia, Bulgaria, Romania and Croatia, respectively. In wild boars seroprevalence rates were up to 10.3%, 30.3% and 31.1% in Romania, Slovenia and Croatia, respectively. A high HEV RNA prevalence in wild boars in some countries (Croatia and Romania) indicated that wild boars may have a key role in the HEV epidemiology. There are very few data on HEV prevalence in environmental samples. HEV RNA was detected in 3.3% and 16.7% surface waters in Slovenia and Serbia, respectively. There is no evidence of HEV RNA in sewage systems in this region. The available data on genetic characterization show that human, animal and environmental HEV strains mainly belong to the genotype 3.

Identifiants

pubmed: 31333309
doi: 10.3748/wjg.v25.i25.3168
pmc: PMC6626717
doi:

Substances chimiques

Hepatitis Antibodies 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

3168-3182

Déclaration de conflit d'intérêts

Conflict-of-interest statement: No potential conflicts of interest. No financial support.

Références

Sante. 2001 Jan-Feb;11(1):13-5
pubmed: 11313227
Bull Soc Pathol Exot. 2002 Mar;95(1):3-7
pubmed: 12012960
Emerg Infect Dis. 2003 Apr;9(4):448-54
pubmed: 12702225
Int J Artif Organs. 2004 Oct;27(10):842-7
pubmed: 15560678
Eur J Intern Med. 2005 Oct;16(6):424-8
pubmed: 16198902
Epidemiol Infect. 2006 Feb;134(1):95-101
pubmed: 16409655
Emerg Infect Dis. 2005 Dec;11(12):1958-60
pubmed: 16485490
Vet Microbiol. 2010 Jan 27;140(3-4):256-65
pubmed: 19361937
Ann Hepatol. 2009 Jul-Sep;8(3):203-6
pubmed: 19841498
J Gastrointestin Liver Dis. 2010 Mar;19(1):43-8
pubmed: 20361074
Vet Res Commun. 2010 Oct;34(7):641-8
pubmed: 20676762
Int J Environ Res Public Health. 2011 Jun;8(6):1914-22
pubmed: 21776209
Infect Genet Evol. 2011 Oct;11(7):1732-7
pubmed: 21802527
Appl Environ Microbiol. 2012 May;78(10):3763-6
pubmed: 22427499
Emerg Infect Dis. 2012 Aug;18(8):1274-81
pubmed: 22840216
Emerg Infect Dis. 2012 Dec;18(12):2085-7
pubmed: 23171845
Food Environ Virol. 2012 Jun;4(2):73-80
pubmed: 23412813
Food Environ Virol. 2012 Dec;4(4):179-91
pubmed: 23412890
J Clin Virol. 2013 Oct;58(2):357-62
pubmed: 23474012
Acta Vet Hung. 2013 Dec;61(4):517-28
pubmed: 23974940
Int J Environ Res Public Health. 2013 Sep 25;10(10):4507-33
pubmed: 24071919
Clin Mol Hepatol. 2013 Sep;19(3):309-14
pubmed: 24133670
Int J Food Microbiol. 2013 Oct 15;167(2):177-85
pubmed: 24135674
Vox Sang. 2014 May;106(4):387
pubmed: 24387713
Emerg Infect Dis. 2014 Jun;20(6):1044-8
pubmed: 24856611
PLoS One. 2014 Jun 04;9(6):e98068
pubmed: 24896257
Eur J Clin Microbiol Infect Dis. 2014 Dec;33(12):2231-6
pubmed: 25005459
J Infect Dev Ctries. 2014 Oct 15;8(10):1322-7
pubmed: 25313610
Int J Infect Dis. 2014 Dec;29:232-7
pubmed: 25447729
Food Environ Virol. 2015 Feb 7;:null
pubmed: 25663146
Food Environ Virol. 2015 Feb 17;:null
pubmed: 25687987
Int J Environ Res Public Health. 2015 Feb 11;12(2):2026-36
pubmed: 25689991
Transbound Emerg Dis. 2015 Jun;62(3):229-32
pubmed: 25773737
Food Environ Virol. 2015 Sep;7(3):195-205
pubmed: 25820413
J Med Virol. 2015 Sep;87(9):1517-20
pubmed: 25965115
Gastroenterology. 2016 Feb;150(2):355-7.e3
pubmed: 26551551
Vector Borne Zoonotic Dis. 2016 Jan;16(1):71-4
pubmed: 26757050
Zoonoses Public Health. 2016 Sep;63(6):494-502
pubmed: 26776465
Clin Infect Dis. 2016 Jun 1;62(11):1464
pubmed: 27025819
Srp Arh Celok Lek. 2016 Jan-Feb;144(1-2):63-8
pubmed: 27276860
Hepatology. 2016 Aug;64(2):350-9
pubmed: 27286751
Emerg Infect Dis. 2016 Jul;22(7):1249-52
pubmed: 27315454
Viruses. 2016 Aug 06;8(8):
pubmed: 27509518
Food Environ Virol. 2017 Mar;9(1):72-78
pubmed: 27709435
Emerg Infect Dis. 2017 Jan;23(1):130-133
pubmed: 27983488
Emerg Infect Dis. 2017 Jul;23(7):1191-1193
pubmed: 28628452
Vet Microbiol. 2017 Sep;208:58-68
pubmed: 28888650
Vox Sang. 2017 Oct;112(7):678-679
pubmed: 28891120
Transbound Emerg Dis. 2018 Apr;65(2):527-533
pubmed: 29027370
Vet Microbiol. 2017 Dec;212:52-58
pubmed: 29173588
Genome Announc. 2018 Apr 19;6(16):null
pubmed: 29674549
PLoS One. 2018 Jun 7;13(6):e0198045
pubmed: 29879148
Epidemiol Infect. 2018 Oct;146(13):1619-1621
pubmed: 29974836
J Med Virol. 2019 Jan;91(1):132-138
pubmed: 30168583
Open Access Maced J Med Sci. 2019 Jan 25;7(3):458-460
pubmed: 30834019
J Hepatol. 1995 Dec;23(6):668-73
pubmed: 8750165
Eur J Epidemiol. 1996 Jun;12(3):297-301
pubmed: 8884198
Transfusion. 1998 Jun;38(6):589-95
pubmed: 9661693

Auteurs

Anna Mrzljak (A)

Department of Medicine, Merkur University Hospital; School of Medicine, University of Zagreb, Zagreb 10000, Grad Zagreb, Croatia. anna.mrzljak@mef.hr.

Petra Dinjar-Kujundzic (P)

Department of Medicine, Merkur University Hospital, Zagreb 10000, Grad Zagreb, Croatia.

Lorena Jemersic (L)

Croatian Veterinary Institute, Zagreb 10000, Grad Zagreb, Croatia.

Jelena Prpic (J)

Croatian Veterinary Institute, Zagreb 10000, Grad Zagreb, Croatia.

Ljubo Barbic (L)

Faculty of Veterinary Medicine, University of Zagreb, Zagreb 10000, Grad Zagreb, Croatia.

Vladimir Savic (V)

Croatian Veterinary Institute, Zagreb 10000, Grad Zagreb, Croatia.

Vladimir Stevanovic (V)

Faculty of Veterinary Medicine, University of Zagreb, Zagreb 10000, Grad Zagreb, Croatia.

Tatjana Vilibic-Cavlek (T)

Department of Virology, Croatian Institute of Public Health; School of Medicine, University of Zagreb, Zagreb 10000, Grad Zagreb, Croatia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH